UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 54

Sortiert nach

Antibiotic therapy against Pseudomonas aeruginosa in cystic fibrosis: a European consensus

The European respiratory journal, 2000-10, Vol.16 (4), p.749-767

2000

Volltextzugriff (PDF)

The pharmacokinetics and toxicity of morning vs. evening tobramycin dosing for pulmonary exacerbations of cystic fibrosis: A randomised comparison

Journal of cystic fibrosis, 2016-07, Vol.15 (4), p.510-517

2016

Volltextzugriff (PDF)

Guidelines for the management of pregnancy in women with cystic fibrosis

Journal of cystic fibrosis, 2008-01, Vol.7, p.S2-S32

2008

Volltextzugriff (PDF)

Population pharmacokinetics of tobramycin administered thrice daily and once daily in children and adults with cystic fibrosis

Journal of cystic fibrosis, 2007-09, Vol.6 (5), p.327-333

2007

Volltextzugriff (PDF)

The influence of breathing mode on tobramycin serum levels using the I-neb AAD system in adults with cystic fibrosis

Journal of cystic fibrosis, 2015-11, Vol.14 (6), p.748-754

2015

Volltextzugriff (PDF)

Dry powder inhalation of colistin in cystic fibrosis patients: A single dose pilot study

Journal of cystic fibrosis, 2007-07, Vol.6 (4), p.284-292

2007

Volltextzugriff (PDF)

WS13.5 Pharmacokinetics and safety of once daily double dose inhaled tobramycin administered with the controlled-inhalation AKITA® and conventional PARI-LC® Plus nebulizer in cystic fibrosis

Journal of cystic fibrosis, 2015-06, Vol.14, p.S26-S26

2015

Volltextzugriff (PDF)

WS14.3 Tobramycin nebulization with the I-neb® in children with cystic fibrosis (TONI study): pharmacokinetics and safety

Journal of cystic fibrosis, 2017-06, Vol.16, p.S25-S26

2017

Volltextzugriff (PDF)

Pre- and postconditioning effects of metformin in rat donor livers

HPB (Oxford, England), 2016-04, Vol.18, p.e546-e547

2016

Volltextzugriff (PDF)

41 Pharmacokinetics of nasally administered tobramycin, colistin sulphomethate sodium and a combination of tobramycin and colistin sulphomethate sodium

Journal of cystic fibrosis, 2014-06, Vol.13, p.S57-S57

2014

Volltextzugriff (PDF)

WS14.5 Influence of breathing pattern on pulmonary aerosol deposition in patients with cystic fibrosis (CF): a pharmacokinetic approach

Journal of cystic fibrosis, 2014-06, Vol.13, p.S30-S30

2014

Volltextzugriff (PDF)

ePS04.7 Tobramycin nebulization with I-neb® in children with cystic fibrosis (TONI study): Pharmacokinetics and safety

Journal of cystic fibrosis, 2015-06, Vol.14, p.S49-S49

2015

Volltextzugriff (PDF)

71 Pharmacokinetics of nasal administered tobramycin in patients with cystic fibrosis

Journal of cystic fibrosis, 2013-06, Vol.12, p.S66-S66

2013

Volltextzugriff (PDF)

197 Influence of inhalation mode on aerosol lung deposition in patients with cystic fibrosis PART 1: Pharmacokinetic data as representative of lung deposition

Journal of cystic fibrosis, 2013-06, Vol.12, p.S98-S98

2013

Volltextzugriff (PDF)

P03-11 Outcome and clinical characteristics of patients intoxicated with Amanita phalloides in a Dutch tertiary center

Toxicology letters, 2022-09, Vol.368, p.S93-S94

2022

Volltextzugriff (PDF)

P03-10 Amanitia Phalloides-induced hematoxicity

Toxicology letters, 2022-09, Vol.368, p.S93

2022

Volltextzugriff (PDF)

Pharmacokinetics and sputum penetration of azithromycin during once weekly dosing in cystic fibrosis patients

Journal of cystic fibrosis, 2008-01, Vol.7 (1), p.79-84

2008

Volltextzugriff (PDF)

Pharmacy compounded pilocarpine: An adequate solution to overcome shortage of pilogel® discs for sweat testing in patients with cystic fibrosis

Journal of cystic fibrosis, 2024-01, Vol.23 (1), p.126-131

2024

Volltextzugriff (PDF)

Test of neural inertia in humans during general anaesthesia

British journal of anaesthesia : BJA, 2018-03, Vol.120 (3), p.525-536

2018

Volltextzugriff (PDF)

Variability in perfusion conditions and set-up parameters used in ex vivo human placenta models: A literature review

Placenta (Eastbourne), 2024-03

2024

Volltextzugriff (PDF)

Does azithromycin inhibit the DNA hydrolysing activity of dornase alpha?

Journal of cystic fibrosis, 2008-06, Vol.7, p.S25-S25

2008

Volltextzugriff (PDF)

P.143 Population pharmacokinetic model and limited sampling strategy for clozapine using plasma and dried blood spot samples

European neuropsychopharmacology, 2020-11, Vol.40, p.S88-S88

2020

Volltextzugriff (PDF)

Phase Ib study of metformin in combination with carboplatin/paclitaxel chemotherapy in patients with advanced epithelial ovarian cancer

Annals of oncology, 2018-10, Vol.29, p.viii354-viii354

2018

Volltextzugriff (PDF)

Drugs during pregnancy and breast feeding in women diagnosed with Cystic Fibrosis - An update

Journal of cystic fibrosis, 2018-01, Vol.17 (1), p.17-25

2018

Volltextzugriff (PDF)

65 Pharmacokinetics of Azithromycin during once weekly dosing in cystic fibrosis patients

Journal of cystic fibrosis, 2007, Vol.6, p.S16-S16

2007

Volltextzugriff (PDF)

1 – 25 von 54

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(52)
Mit Volltextzugriff
(49)

Publikationsform

Artikel
(53)
Berichte
(1)

Sprache

Englisch
(54)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(23)
Science & Technology
(23)
Humans
(19)
Pulmonary/respiratory
(18)
Male
(13)
Female
(12)
Adult
(10)
Cystic Fibrosis
(10)
Respiratory System
(10)
Anti-Bacterial Agents - Pharmacokinetics
(8)
Biological And Medical Sciences
(8)
Medical Sciences
(8)
Anti-Bacterial Agents - Administration & Dosage
(7)
Cystic Fibrosis - Drug Therapy
(7)
Middle Aged
(7)
Pharmacology. Drug Treatments
(7)
Administration, Inhalation
(5)
Cross-Over Studies
(5)
Pharmacokinetics
(5)
Pharmacology & Pharmacy
(5)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Antibiotic therapy against Pseudomonas aeruginosa in cystic fibrosis: a European consensus

The pharmacokinetics and toxicity of morning vs. evening tobramycin dosing for pulmonary exacerbations of cystic fibrosis: A randomised comparison

Guidelines for the management of pregnancy in women with cystic fibrosis

Population pharmacokinetics of tobramycin administered thrice daily and once daily in children and adults with cystic fibrosis

The influence of breathing mode on tobramycin serum levels using the I-neb AAD system in adults with cystic fibrosis

Dry powder inhalation of colistin in cystic fibrosis patients: A single dose pilot study

WS13.5 Pharmacokinetics and safety of once daily double dose inhaled tobramycin administered with the controlled-inhalation AKITA® and conventional PARI-LC® Plus nebulizer in cystic fibrosis

WS14.3 Tobramycin nebulization with the I-neb® in children with cystic fibrosis (TONI study): pharmacokinetics and safety

Pre- and postconditioning effects of metformin in rat donor livers

41 Pharmacokinetics of nasally administered tobramycin, colistin sulphomethate sodium and a combination of tobramycin and colistin sulphomethate sodium

WS14.5 Influence of breathing pattern on pulmonary aerosol deposition in patients with cystic fibrosis (CF): a pharmacokinetic approach

ePS04.7 Tobramycin nebulization with I-neb® in children with cystic fibrosis (TONI study): Pharmacokinetics and safety

71 Pharmacokinetics of nasal administered tobramycin in patients with cystic fibrosis

197 Influence of inhalation mode on aerosol lung deposition in patients with cystic fibrosis PART 1: Pharmacokinetic data as representative of lung deposition

P03-11 Outcome and clinical characteristics of patients intoxicated with Amanita phalloides in a Dutch tertiary center

P03-10 Amanitia Phalloides-induced hematoxicity

Pharmacokinetics and sputum penetration of azithromycin during once weekly dosing in cystic fibrosis patients

Pharmacy compounded pilocarpine: An adequate solution to overcome shortage of pilogel® discs for sweat testing in patients with cystic fibrosis

Test of neural inertia in humans during general anaesthesia

Variability in perfusion conditions and set-up parameters used in ex vivo human placenta models: A literature review

Does azithromycin inhibit the DNA hydrolysing activity of dornase alpha?

P.143 Population pharmacokinetic model and limited sampling strategy for clozapine using plasma and dried blood spot samples

Phase Ib study of metformin in combination with carboplatin/paclitaxel chemotherapy in patients with advanced epithelial ovarian cancer

Drugs during pregnancy and breast feeding in women diagnosed with Cystic Fibrosis - An update

65 Pharmacokinetics of Azithromycin during once weekly dosing in cystic fibrosis patients

Suchergebnisse filtern